Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00936728 · ClinicalTrials.gov registry record · NA
White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer
A NA study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Academic and Community Cancer Research United.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 4
- Study locations
NCT00936728: Completed NA study of Unspecified Adult Solid Tumor, Protocol Specific, sponsored by Academic and Community Cancer Research United.
NCT00936728 is a NA study of Unspecified Adult Solid Tumor, Protocol Specific that has completed, run by Academic and Community Cancer Research United. The registered enrollment target is 140 participants, below the 499-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (72% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00936728, a NA study of Unspecified Adult Solid Tumor, Protocol Specific, has completed, sponsored by Academic and Community Cancer Research United.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 4
- Study locations
Study Summary
RATIONALE: It is not yet know whether white wine is more effective than a nutritional supplement in improving appetite. PURPOSE: This randomized clinical trial is studying white wine to see how well it works compared with a nutritional supplement in improving appetite in patients with cancer
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER therapeutic nutritional supplementation
- DIETARY_SUPPLEMENT white wine
Study Locations (4)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Pennsylvania
- Geisinger Medical Center - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2009-07 |
| Est. Completion | 2017-04-17 |
| Phase | NA |
What the finished NCT00936728 record still lists
NCT00936728 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 499-participant average among 83 other Unspecified Adult Solid Tumor, Protocol Specific trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00936728 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00936728 about?
NCT00936728 is a clinical study titled "White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer". RATIONALE: It is not yet know whether white wine is more effective than a nutritional supplement in improving appetite. PURPOSE: This randomized clinical trial is studying white wine to see how well it works compared with a nutritional supplement in improving appetite in patients with cancer
What is the current status of trial NCT00936728?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2009-07. Estimated completion is 2017-04-17.
What conditions does trial NCT00936728 study?
This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific.
What interventions are being tested in trial NCT00936728?
The interventions under investigation include: questionnaire administration (OTHER), therapeutic nutritional supplementation (OTHER), white wine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00936728?
This trial is sponsored by Academic and Community Cancer Research United, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00936728 being conducted?
This trial has 4 study locations across Arizona, Florida, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Adult Solid Tumor, Protocol Specific
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00936728's enrollment target sits among peer trials
140 15th of 83 higher than 68 of 83 other Unspecified Adult Solid Tumor, Protocol Specific trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Unspecified Adult Solid Tumor, Protocol Specific trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment Tool for Older Patients With Cancer
ACTIVE NOT RECRUITING · NA
-
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
COMPLETED · NA
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
RECRUITING
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
RECRUITING
-
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
RECRUITING
-
Registry of Older Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia